Should You Buy Revvity Inc (RVTY) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Revvity Inc (RVTY) is not a strong buy for a beginner investor with a long-term strategy at this time. While the technical indicators show a bullish trend, the lack of significant positive catalysts, weak financial performance in the latest quarter, and mixed analyst ratings suggest that the stock does not present a compelling long-term investment opportunity right now. Holding off for better financial performance or stronger signals is recommended.
Technical Analysis
The technical indicators show a bullish trend with MACD above 0 and positively contracting, RSI at 72.821 in the neutral zone, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 117.067), which could act as a barrier for further upward movement.
Analyst Ratings and Price Target Trends
Analyst ratings are mixed. Evercore ISI and Barclays raised price targets and maintained positive ratings, citing recovering end markets and sector rotation. However, BofA downgraded the stock to Neutral, and Goldman Sachs initiated coverage with a Neutral rating, citing cautious views on U.S. academic/government spending and drug discovery recovery timing.
Wall Street analysts forecast RVTY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVTY is 113.38 USD with a low forecast of 105 USD and a high forecast of 123 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast RVTY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVTY is 113.38 USD with a low forecast of 105 USD and a high forecast of 123 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 111.130
Current: 111.130
